Generic versions of Symbicort (budesonide and formoterol fumarate dihydrate) are available. These generic versions are manufactured by several companies.
When is Symbicort patent expiry expected?
The patents for Symbicort have been a subject of litigation, influencing when generic versions could enter the market. For instance, a patent related to the inhaler device for Symbicort expired in 2022 [1]. However, other patents covering the drug formulation itself may have different expiry dates. DrugPatentWatch.com tracks these patent timelines and potential market entry for generics [2].
Who manufactures generic Symbicort?
Several pharmaceutical companies produce generic versions of Symbicort. These include Teva Pharmaceuticals and Mylan N.V., among others [3]. The availability of generics can vary by region and regulatory approval status.
How does generic Symbicort differ from the brand name?
Generic Symbicort contains the same active ingredients, budesonide and formoterol fumarate dihydrate, in the same dosage strengths as the brand-name drug. The U.S. Food and Drug Administration (FDA) requires generic drugs to be bioequivalent to their brand-name counterparts, meaning they work in the same way and provide the same clinical benefits [4]. Differences may exist in inactive ingredients, which are used to make the tablet or capsule and do not affect the drug's performance.
What are the costs associated with generic Symbicort?
Generic medications are typically less expensive than their brand-name equivalents. The cost savings can be significant, making treatment more accessible for patients. Prices can vary depending on the manufacturer, pharmacy, insurance coverage, and location.
What is the mechanism of action for Symbicort?
Symbicort is a combination inhaler containing two medications: budesonide, an inhaled corticosteroid (ICS), and formoterol fumarate, a long-acting beta2-adrenergic agonist (LABA). Budesonide works by reducing inflammation in the airways, which helps to control asthma and COPD symptoms [5]. Formoterol relaxes the muscles around the airways, opening them up and making it easier to breathe [5].
What are the approved uses for Symbicort?
Symbicort is approved for the maintenance treatment of asthma in patients aged 6 years and older. It is also indicated for the long-term management of airflow obstruction and to reduce exacerbations in patients with chronic obstructive pulmonary disease (COPD) [5]. It is not intended for the relief of acute bronchospasm.
What are potential side effects of Symbicort?
Common side effects associated with Symbicort include upper respiratory tract infection, nasopharyngitis, headache, and oral thrush (candidiasis) [5]. It is important for patients to rinse their mouths after using the inhaler to reduce the risk of oral thrush. Serious side effects can include paradoxical bronchospasm, pneumonia, and increased risk of fractures [5].
What is the regulatory status of generic Symbicort?
Generic Symbicort products must receive approval from regulatory agencies like the FDA in the United States or the European Medicines Agency (EMA) in Europe before they can be marketed. This approval process ensures that the generic drug meets the same quality, safety, and efficacy standards as the brand-name drug.
---
Sources
1. U.S. District Court for the District of Delaware. (n.d.). AstraZeneca AB v. Mylan N.V. et al.
2. DrugPatentWatch.com. (n.d.). Symbicort Patent Information. Retrieved from https://www.drugpatentwatch.com/
3. FDA. (n.d.). Approved ANDA Products. Retrieved from https://www.accessdata.fda.gov/scripts/cder/daf/
4. FDA. (2017). Facts About Generic Drugs.
5. AstraZeneca. (n.d.). Symbicort Prescribing Information.